Measuring muscle mass and stiffness in COPD patients
Official title: Clinimetric Properties Assessment of Quadriceps Muscle Mass and Stiffness Using Perimetry and ShearWave Elastography in Patients With COPD : a Prospective Observational Study
Run by Groupe Hospitalier du Havre · NCT06994689 · Data updated 2026-11-12
This study is testing simple ways to measure muscle mass and stiffness in people with COPD to see if these methods can help track their muscle health before and after rehab.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Groupe Hospitalier du Havre Academic / other |
| Locations | 1 site (Le Havre) |
| Status | Recruiting |
| Started | May 30, 2025 |
| Main results expected | October 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | January 21, 2026 |
| Trial ID | NCT06994689 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old who have been diagnosed with COPD and are starting a pulmonary rehabilitation program.
✕Probably not a fit
Patients who may not benefit from this study include those with lower limb amputations, neuromuscular diseases, or cardiovascular contraindications for pulmonary rehabilitation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the clinimetric properties of quadriceps muscle mass and stiffness measurements in patients with Chronic Obstructive Pulmonary Disease (COPD). It aims to assess the validity and reliability of simple methods like perimetric tape measurement and ShearWave elastography to monitor muscle function. By evaluating these measurements before and after a pulmonary rehabilitation program, the study seeks to improve the management of muscle dysfunction associated with COPD. The findings could lead to better monitoring strategies that could enhance patient outcomes.
Why it matters
Potential benefit: If successful, this study could provide a cost-effective method for early detection and monitoring of muscle dysfunction in COPD patients, potentially improving their quality of life and management.
How similar studies have gone: While the approach of using simple measurement techniques for muscle assessment is established, the specific application of ShearWave elastography in COPD patients is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * COPD patients * Adults (\>18 years old) * Patients starting a pulmonary rehabilitation (PR) programme Exclusion Criteria: * Patients included in other research protocol * Minors or under guardianship * Pregnancy * Patients with lower limb amputation or history of neuromuscular disease * Cardiovascular contradications for PR
Where it's running
-
Groupe Hospitalier du Havre
Le Havre, France Recruiting
Study contacts
- Study coordinator: Claire Dubois, PT
- Email: claire.dubois@ch-havre.fr
- Phone: (+33)630039745
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
Continuous vs High-Intensity Interval Exercise in COPD
This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.
-
Biomarker clues for COPD, IPF, and lung cancer
This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.
-
HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults
This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.